» Articles » PMID: 38967905

The Role of the Neural Exposome As a Novel Strategy to Identify and Mitigate Health Inequities in Alzheimer's Disease and Related Dementias

Overview
Journal Mol Neurobiol
Date 2024 Jul 5
PMID 38967905
Authors
Affiliations
Soon will be listed here.
Abstract

With the continuous increase of the elderly population, there is an urgency to understand and develop relevant treatments for Alzheimer's disease and related dementias (ADRD). In tandem with this, the prevalence of health inequities continues to rise as disadvantaged communities fail to be included in mainstream research. The neural exposome poses as a relevant mechanistic approach and tool for investigating ADRD onset, progression, and pathology as it accounts for several different factors: exogenous, endogenous, and behavioral. Consequently, through the neural exposome, health inequities can be addressed in ADRD research. In this paper, we address how the neural exposome relates to ADRD by contributing to the discourse through defining how the neural exposome can be developed as a tool in accordance with machine learning. Through this, machine learning can allow for developing a greater insight into the application of transferring and making sense of experimental mouse models exposed to health inequities and potentially relate it to humans. The overall goal moving beyond this paper is to define a multitude of potential factors that can increase the risk of ADRD onset and integrate them to create an interdisciplinary approach to the study of ADRD and subsequently translate the findings to clinical research.

References
1.
Hosna A, Merry E, Gyalmo J, Alom Z, Aung Z, Azim M . Transfer learning: a friendly introduction. J Big Data. 2022; 9(1):102. PMC: 9589764. DOI: 10.1186/s40537-022-00652-w. View

2.
Bobb J, Obermeyer Z, Wang Y, Dominici F . Cause-specific risk of hospital admission related to extreme heat in older adults. JAMA. 2014; 312(24):2659-67. PMC: 4319792. DOI: 10.1001/jama.2014.15715. View

3.
Elias M, Elias P, Sullivan L, Wolf P, DAgostino R . Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study. Int J Obes Relat Metab Disord. 2003; 27(2):260-8. DOI: 10.1038/sj.ijo.802225. View

4.
Vogt N, Kerby R, Dill-McFarland K, Harding S, Merluzzi A, Johnson S . Gut microbiome alterations in Alzheimer's disease. Sci Rep. 2017; 7(1):13537. PMC: 5648830. DOI: 10.1038/s41598-017-13601-y. View

5.
Herr D, Jew K, Wong C, Kennell A, Gelein R, Chalupa D . Effects of concentrated ambient ultrafine particulate matter on hallmarks of Alzheimer's disease in the 3xTgAD mouse model. Neurotoxicology. 2021; 84:172-183. PMC: 8268836. DOI: 10.1016/j.neuro.2021.03.010. View